Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer

NCT01048099 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

283

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

PROCEDURE: PRO Onc Assay and Treatment
DRUG: Trastuzumab
DRUG: Pertuzumab

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]